+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Meningitis Imaging Market By Product Type, By Disease Type, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • PDF Icon

    Report

  • 94 Pages
  • January 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5553023
The Europe Meningitis Imaging Market is expected to witness market growth of 3.9% CAGR during the forecast period (2021-2027).

There is an increase in the geriatric population across this region, who are more vulnerable to infections or diseases like meningitis. Moreover, the rising advancements in technology and the launch of the various latest equipment with better scanning capacities for diagnosing meningitis is motivating hospitals and clinicians to adopt them for better imaging process. Along with that, HIV/AIDS prevention, treatment, and care are gaining more significance in Europe over the last few decades.

Other historical data, such as the duration of symptoms, sexual history, immunization history, drug usage history, personal history of tuberculosis, travel history, and place of origin, is particularly helpful in determining the various causes of meningitis. Symptoms and history are useful in narrowing the etiologic possibilities, but they are unreliable in determining whether meningitis is present or not.

This knowledge must be combined with a thorough awareness of the situation's basic epidemiology knowing which varieties of meningitis are typical in a certain patient's history guides diagnostic testing. When all of this information is combined, the provider can quickly order diagnostic testing to try to make a definitive diagnosis.

The Germany market dominated the Europe Meningitis Imaging Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $14.4 Thousands by 2027. The UK market is expected to witness a CAGR of 3.1% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 4.7% during (2021 - 2027).

Based on Product Type, the market is segmented into Computer Tomography (CT), Magnetic Resonance Imaging (MRI) and Positron Emission Tomography. Based on Disease Type, the market is segmented into Viral Meningitis, Fungal Meningitis, Bacterial Meningitis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Diagnostic Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shimadzu Corporation, Accuray, Incorporated, United Imaging Healthcare Co., Ltd., Positron Corporation, Neusoft Medical Systems Co., Ltd. (Neusoft Corporation), Siemens AG (Siemens Healthineers), Fujifilm Holdings Corporation, General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., and Canon, Inc. (Canon Medical Systems Corporation).

Scope of the Study


Market Segments Covered in the Report:


By Product Type

  • Computer Tomography (CT)
  • Magnetic Resonance Imaging (MRI) and
  • Positron Emission Tomography

By Disease Type

  • Viral Meningitis
  • Fungal Meningitis
  • Bacterial Meningitis and
  • Others

By End User

  • Hospitals & Clinics and
  • Diagnostic Centers

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players


List of Companies Profiled in the Report:

  • Shimadzu Corporation
  • Accuray, Incorporated
  • United Imaging Healthcare Co., Ltd.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
  • Siemens AG (Siemens Healthineers)
  • Fujifilm Holdings Corporation
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Canon, Inc. (Canon Medical Systems Corporation)

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Meningitis Imaging Market, by Product Type
1.4.2 Europe Meningitis Imaging Market, by Disease Type
1.4.3 Europe Meningitis Imaging Market, by End User
1.4.4 Europe Meningitis Imaging Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions 2021, Aug - 2021, Dec) Leading Players
Chapter 4. Europe Meningitis Imaging Market by Product Type
4.1 Europe Computer Tomography (CT) Market by Country
4.2 Europe Magnetic Resonance Imaging (MRI) Market by Country
4.3 Europe Positron Emission Tomography Market by Country
Chapter 5. Europe Meningitis Imaging Market by Disease Type
5.1 Europe Viral Meningitis Market by Country
5.2 Europe Fungal Meningitis Market by Country
5.3 Europe Bacterial Meningitis Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Meningitis Imaging Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Diagnostic Centers Market by Country
Chapter 7. Europe Meningitis Imaging Market by Country
7.1 Germany Meningitis Imaging Market
7.1.1 Germany Meningitis Imaging Market by Product Type
7.1.2 Germany Meningitis Imaging Market by Disease Type
7.1.3 Germany Meningitis Imaging Market by End User
7.2 UK Meningitis Imaging Market
7.2.1 UK Meningitis Imaging Market by Product Type
7.2.2 UK Meningitis Imaging Market by Disease Type
7.2.3 UK Meningitis Imaging Market by End User
7.3 France Meningitis Imaging Market
7.3.1 France Meningitis Imaging Market by Product Type
7.3.2 France Meningitis Imaging Market by Disease Type
7.3.3 France Meningitis Imaging Market by End User
7.4 Russia Meningitis Imaging Market
7.4.1 Russia Meningitis Imaging Market by Product Type
7.4.2 Russia Meningitis Imaging Market by Disease Type
7.4.3 Russia Meningitis Imaging Market by End User
7.5 Spain Meningitis Imaging Market
7.5.1 Spain Meningitis Imaging Market by Product Type
7.5.2 Spain Meningitis Imaging Market by Disease Type
7.5.3 Spain Meningitis Imaging Market by End User
7.6 Italy Meningitis Imaging Market
7.6.1 Italy Meningitis Imaging Market by Product Type
7.6.2 Italy Meningitis Imaging Market by Disease Type
7.6.3 Italy Meningitis Imaging Market by End User
7.7 Rest of Europe Meningitis Imaging Market
7.7.1 Rest of Europe Meningitis Imaging Market by Product Type
7.7.2 Rest of Europe Meningitis Imaging Market by Disease Type
7.7.3 Rest of Europe Meningitis Imaging Market by End User
Chapter 8. Company Profiles
8.1 Shimadzu Corporation
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments
8.1.4.1 Acquisition and Mergers:
8.2 Accuray Incorporated
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments
8.2.5.1 Product Launches and Product Expansions
8.3 United Imaging Healthcare Co., Ltd.
8.3.1 Company Overview
8.4 Positron Corporation
8.4.1 Company Overview
8.5 Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments
8.6.5.1 Product Launches and Product Expansions
8.6.5.2 Acquisition and Mergers:
8.7 Fujifilm Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments
8.7.5.1 Acquisitions and Mergers:
8.7.5.2 Product Launches and Product Expansions
8.8 General Electric (GE) Co. (GE Healthcare)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.8.6 SWOT Analysis
8.9 Koninklijke Philips N.V.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments
8.9.5.1 Partnerships, Collaborations, and Agreements
8.10. Canon, Inc. (Canon Medical Systems Corporation)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments
8.10.5.1 Partnerships, Collaborations, and Agreements
8.10.5.2 Product Launches and Product Expansions
8.10.5.3 Acquisition and Mergers:

Companies Mentioned

  • Shimadzu Corporation
  • Accuray, Incorporated
  • United Imaging Healthcare Co., Ltd.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
  • Siemens AG (Siemens Healthineers)
  • Fujifilm Holdings Corporation
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Canon, Inc. (Canon Medical Systems Corporation)

Methodology

Loading
LOADING...